DOI:
10.1055/s-00000002
Aktuelle Dermatologie
LinksClose Window
References
Younes A, Bartlett NL, Leonard JP. et al.
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.
N Engl J Med 2010;
363: 1812-1821
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.